PureTech Health plc (LON:PRTC – Get Free Report) shares crossed above its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of GBX 205.24 ($2.55) and traded as high as GBX 212 ($2.64). PureTech Health shares last traded at GBX 209 ($2.60), with a volume of 230,882 shares traded.
PureTech Health Stock Performance
The company has a current ratio of 7.31, a quick ratio of 2.51 and a debt-to-equity ratio of 25.41. The stock’s 50 day moving average price is GBX 205.24 and its two-hundred day moving average price is GBX 184.50. The firm has a market capitalization of £562.85 million, a PE ratio of -1,607.69 and a beta of 0.94.
PureTech Health Company Profile
PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule.
Featured Articles
- Five stocks we like better than PureTech Health
- How to Most Effectively Use the MarketBeat Earnings Screener
- United Airlines Soars on Earnings Beat
- 10 Best Airline Stocks to Buy
- J.B. Hunt Hits the Skids: Lower Prices to Come
- The “How” and “Why” of Investing in 5G Stocks
- Predicting a Bear Market: 7 Signs and Why it’s Tough to Do
Receive News & Ratings for PureTech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureTech Health and related companies with MarketBeat.com's FREE daily email newsletter.
